136 related articles for article (PubMed ID: 22461449)
1. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
2. Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.
Zhang Y; Zhang Y; Klaassen CD; Cheng X
Toxicol Sci; 2018 Mar; 162(1):225-233. PubMed ID: 29112762
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Ghallab A; González D; Strängberg E; Hofmann U; Myllys M; Hassan R; Hobloss Z; Brackhagen L; Begher-Tibbe B; Duda JC; Drenda C; Kappenberg F; Reinders J; Friebel A; Vucur M; Turajski M; Seddek AL; Abbas T; Abdelmageed N; Morad SAF; Morad W; Hamdy A; Albrecht W; Kittana N; Assali M; Vartak N; van Thriel C; Sous A; Nell P; Villar-Fernandez M; Cadenas C; Genc E; Marchan R; Luedde T; Åkerblad P; Mattsson J; Marschall HU; Hoehme S; Stirnimann G; Schwab M; Boor P; Amann K; Schmitz J; Bräsen JH; Rahnenführer J; Edlund K; Karpen SJ; Simbrunner B; Reiberger T; Mandorfer M; Trauner M; Dawson PA; Lindström E; Hengstler JG
J Hepatol; 2024 Feb; 80(2):268-281. PubMed ID: 37939855
[TBL] [Abstract][Full Text] [Related]
4. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
5. Organic Anion Transporting Polypeptide (OATP) 1B3 is a Significant Transporter for Hepatic Uptake of Conjugated Bile Acids in Humans.
Pan Q; Zhu G; Xu Z; Zhu J; Ouyang J; Tong Y; Zhao N; Zhang X; Cheng Y; Zhang L; Tan Y; Li J; Zhang C; Chen W; Cai SY; Boyer JL; Chai J
Cell Mol Gastroenterol Hepatol; 2023; 16(2):223-242. PubMed ID: 37146714
[TBL] [Abstract][Full Text] [Related]
6. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
[TBL] [Abstract][Full Text] [Related]
7. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
[TBL] [Abstract][Full Text] [Related]
8. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
[TBL] [Abstract][Full Text] [Related]
9. A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury.
Taylor SA; Yeap XY; Wang JJ; Gromer KD; Kriegermeier A; Green RM; Zhang ZJ
Physiol Rep; 2020 May; 8(10):e14446. PubMed ID: 32441483
[TBL] [Abstract][Full Text] [Related]
10. miR-194 Up-Regulates Cholesterol 7 Alpha-Hydroxylase Expression via β-Catenin Signaling and Aggravates Cholestatic Liver Diseases.
Chen PC; Hsu CP; Wang SY; Wu TY; Lin YJ; Chen YT; Hsu SH
Am J Pathol; 2023 Jun; 193(6):755-768. PubMed ID: 36868469
[TBL] [Abstract][Full Text] [Related]
11. C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice.
Liu R; Li X; Huang Z; Zhao D; Ganesh BS; Lai G; Pandak WM; Hylemon PB; Bajaj JS; Sanyal AJ; Zhou H
Hepatology; 2018 Apr; 67(4):1441-1457. PubMed ID: 28926118
[TBL] [Abstract][Full Text] [Related]
12. Prominin-1-expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury.
Fenlon M; Short C; Xu J; Malkoff N; Mahdi E; Hough M; Glazier A; Lee C; Asahina K; Wang KS
Physiol Rep; 2020 Jul; 8(14):e14508. PubMed ID: 32686913
[TBL] [Abstract][Full Text] [Related]
13. Hepatic LGR4 aggravates cholestasis-induced liver injury in mice.
Gao Y; Zhai W; Sun L; Du X; Wang X; Mulholland MW; Yin Y; Zhang W
Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G460-G472. PubMed ID: 38440827
[TBL] [Abstract][Full Text] [Related]
14. Does lithium attenuate the liver damage due to oxidative stress and liver glycogen depletion in experimental common bile duct obstruction?
Engin AB; Engin A; Engin ED; Memis L
Toxicol Appl Pharmacol; 2023 May; 466():116489. PubMed ID: 36963521
[TBL] [Abstract][Full Text] [Related]
15. Single-cell sequencing of a novel model of neonatal bile duct ligation in mice identifies macrophage heterogeneity in obstructive cholestasis.
Antala S; Gromer KD; Gadhvi G; Kriegermeier A; Wang JJ; Abdala-Valencia H; Wechsler JB; Perlman H; Winter DR; Zhang ZJ; Green RM; Taylor SA
Sci Rep; 2023 Aug; 13(1):14104. PubMed ID: 37644108
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Deficiency Exacerbates Liver Injury in Bile Duct Ligated Mice via Inflammation and Lipid Metabolism.
Zhou X; Zhang X; Zhao N; Zhang L; Qiu W; Song C; Chai J; Cai S; Chen W
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834588
[TBL] [Abstract][Full Text] [Related]
17. Renal Pharmacokinetic Adaptation to Cholestasis Causes Increased Nephrotoxic Drug Accumulation by Mrp6 Downregulation in Mice.
Arakawa H; Kawanishi T; Shengyu D; Nishiuchi T; Meguro-Horike M; Horike SI; Sugimoto M; Kato Y
J Pharm Sci; 2023 Dec; 112(12):3209-3215. PubMed ID: 37611664
[TBL] [Abstract][Full Text] [Related]
18. Melatonin improves cholestatic liver disease via the gut-liver axis.
Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y
J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury.
Shearn CT; Anderson AL; Miller CG; Noyd RC; Devereaux MW; Balasubramaniyan N; Orlicky DJ; Schmidt EE; Sokol RJ
Hepatol Commun; 2023 Jan; 7(1):e0020. PubMed ID: 36633484
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting Wnt Signaling Reduces Cholestatic Injury by Disrupting the Inflammatory Axis.
Ayers M; Kosar K; Xue Y; Goel C; Carson M; Lee E; Liu S; Brooks E; Cornuet P; Oertel M; Bhushan B; Nejak-Bowen K
Cell Mol Gastroenterol Hepatol; 2023; 16(6):895-921. PubMed ID: 37579970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
